Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KPTI

Karyopharm

$18.50

0.47 (2.61%)

, VYGR

Voyager Therapeutics

$18.11

0.39 (2.20%)

04:55
08/15/18
08/15
04:55
08/15/18
04:55
Conference/Events
Wedbush to hold a conference »

2018 Wedbush PacGrow…

KPTI

Karyopharm

$18.50

0.47 (2.61%)

VYGR

Voyager Therapeutics

$18.11

0.39 (2.20%)

VRNA

Verona Pharma

$13.10

-0.3 (-2.24%)

AVRO

AvroBio

$40.52

-0.08 (-0.20%)

ASND

Ascendis Pharma

$67.70

-0.8 (-1.17%)

OBSV

ObsEva

$12.98

-1.02 (-7.29%)

OMER

Omeros

$20.63

1.45 (7.56%)

NVCR

Novocure

$36.85

-0.1 (-0.27%)

XNCR

Xencor

$40.97

0.28 (0.69%)

PRTK

Paratek Pharmaceuticals

$10.10

0.45 (4.66%)

MGTA

Magenta Therapeutics

$12.99

0.09 (0.70%)

CRVS

Corvus Pharmaceuticals

$9.03

-0.4 (-4.24%)

AKAO

Achaogen

$5.66

-0.165 (-2.84%)

ALBO

Albireo Pharma

$31.77

0.17 (0.54%)

EIGR

Eiger BioPharmaceuticals

$10.05

0.375 (3.88%)

STML

Stemline

$15.40

0.25 (1.65%)

SRRA

Sierra Oncology

$1.95

-0.11 (-5.34%)

ABUS

Arbutus Biopharma

$9.20

-0.45 (-4.66%)

MRSN

Mersana Therapeutics

$12.75

0.04 (0.31%)

SRRK

Scholar Rock

$14.00

0.71 (5.34%)

ARGX

Argenx

$87.50

0.19 (0.22%)

ALNA

Allena Pharmaceuticals

$10.98

0.11 (1.01%)

KURA

Kura Oncology

$19.75

-0.2 (-1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

  • 19

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 05

    Sep

  • 21

    Feb

Tuesday
KPTI

Karyopharm

$18.03

-0.04 (-0.22%)

, VYGR

Voyager Therapeutics

$17.72

-0.44 (-2.42%)

09:08
08/14/18
08/14
09:08
08/14/18
09:08
Conference/Events
Wedbush to hold a conference »

2018 Wedbush PacGrow…

KPTI

Karyopharm

$18.03

-0.04 (-0.22%)

VYGR

Voyager Therapeutics

$17.72

-0.44 (-2.42%)

VRNA

Verona Pharma

$13.40

-0.47 (-3.39%)

AVRO

AvroBio

$40.60

0.61 (1.53%)

ASND

Ascendis Pharma

$68.50

0.82 (1.21%)

OBSV

ObsEva

$14.00

-0.96 (-6.42%)

OMER

Omeros

$19.18

1.41 (7.93%)

NVCR

Novocure

$36.95

1 (2.78%)

XNCR

Xencor

$40.69

0.38 (0.94%)

PRTK

Paratek Pharmaceuticals

$9.65

-0.4 (-3.98%)

MGTA

Magenta Therapeutics

$12.90

-0.16 (-1.23%)

CRVS

Corvus Pharmaceuticals

$9.43

0.12 (1.29%)

AKAO

Achaogen

$5.82

-0.35 (-5.67%)

ALBO

Albireo Pharma

$31.60

0.42 (1.35%)

EIGR

Eiger BioPharmaceuticals

$9.68

0.025 (0.26%)

STML

Stemline

$15.15

0.15 (1.00%)

SRRA

Sierra Oncology

$2.06

(0.00%)

ABUS

Arbutus Biopharma

$9.65

0.15 (1.58%)

MRSN

Mersana Therapeutics

$12.71

-0.205 (-1.59%)

SRRK

Scholar Rock

$13.29

-1.11 (-7.71%)

ARGX

Argenx

$87.31

-2.79 (-3.10%)

ALNA

Allena Pharmaceuticals

$10.87

0.13 (1.21%)

KURA

Kura Oncology

$19.95

0.95 (5.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 19

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 05

    Sep

  • 21

    Feb

Over a week ago
PRTK

Paratek Pharmaceuticals

$10.55

-0.35 (-3.21%)

09:14
08/09/18
08/09
09:14
08/09/18
09:14
Recommendations
Paratek Pharmaceuticals analyst commentary at Wedbush »

Tone of Paratek advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

PRTK

Paratek Pharmaceuticals

$11.15

0.25 (2.29%)

15:41
08/08/18
08/08
15:41
08/08/18
15:41
Recommendations
Paratek Pharmaceuticals analyst commentary at Raymond James »

AdCom vote increases…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 14

    Aug

PRTK

Paratek Pharmaceuticals

$10.90

(0.00%)

14:53
08/08/18
08/08
14:53
08/08/18
14:53
Hot Stocks
Paratek says FDA AdComm votes 'positive' for both omadacycline indications »

Paratek Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 14

    Aug

PRTK

Paratek Pharmaceuticals

$10.90

(0.00%)

14:50
08/08/18
08/08
14:50
08/08/18
14:50
Hot Stocks
Breaking Hot Stocks news story on Paratek Pharmaceuticals »

Paratek Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 14

    Aug

PRTK

Paratek Pharmaceuticals

$10.90

(0.00%)

13:03
08/08/18
08/08
13:03
08/08/18
13:03
Periodicals
FDA advisors back safety, efficacy of Paratek's omadacycline to treat pneumonia »

An FDA advisory committee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 14

    Aug

PRTK

Paratek Pharmaceuticals

$10.90

(0.00%)

12:57
08/08/18
08/08
12:57
08/08/18
12:57
Periodicals
FDA advisors say Paratek showed evidence of omadacycline safety, effectiveness »

An FDA advisory committee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 14

    Aug

PRTK

Paratek Pharmaceuticals

$10.90

-0.05 (-0.46%)

08:07
08/08/18
08/08
08:07
08/08/18
08:07
Conference/Events
The FDA Antimicrobial Drugs Advisory Committee to hold a meeting »

The Committee discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 14

    Aug

PRTK

Paratek Pharmaceuticals

$10.90

-0.05 (-0.46%)

06:55
08/08/18
08/08
06:55
08/08/18
06:55
Hot Stocks
Breaking Hot Stocks news story on Paratek Pharmaceuticals »

Paratek Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 14

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.